These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Advances in the treatment of depression. Holtzheimer PE; Nemeroff CB NeuroRx; 2006 Jan; 3(1):42-56. PubMed ID: 16490412 [TBL] [Abstract][Full Text] [Related]
83. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. Herpfer I; Lieb K CNS Drugs; 2005; 19(4):275-93. PubMed ID: 15813642 [TBL] [Abstract][Full Text] [Related]
84. Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Ebner K; Rupniak NM; Saria A; Singewald N Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4280-5. PubMed ID: 15024126 [TBL] [Abstract][Full Text] [Related]
85. Neuropeptides involved in the pathophysiology of schizophrenia and major depression. De Wied D; Sigling HO Neurotox Res; 2002; 4(5-6):453-468. PubMed ID: 12754159 [TBL] [Abstract][Full Text] [Related]
86. Idiopathic pain and depression. von Knorring L; Ekselius L Qual Life Res; 1994 Dec; 3 Suppl 1():S57-68. PubMed ID: 7866374 [TBL] [Abstract][Full Text] [Related]
87. Growth hormone releasing factor in human cerebrospinal fluid. Berrettini WH; Nurnberger JI; Simmons-Alling S Psychiatry Res; 1987 Oct; 22(2):141-7. PubMed ID: 3120205 [TBL] [Abstract][Full Text] [Related]
88. CSF somatostatin in affective illness and normal volunteers. Rubinow DR; Gold PW; Post RM; Ballenger JC Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):393-400. PubMed ID: 2866561 [TBL] [Abstract][Full Text] [Related]
89. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. Naber D; Pickar D; Post RM; Van Kammen DP; Waters RN; Ballenger JC; Goodwin FK; Bunney WE Am J Psychiatry; 1981 Nov; 138(11):1457-62. PubMed ID: 6271019 [TBL] [Abstract][Full Text] [Related]
90. Elevated cerebrospinal fluid protein in men with unipolar or bipolar depression. Samuelson SD; Winokur G; Pitts AF Biol Psychiatry; 1994 Apr; 35(8):539-44. PubMed ID: 8038297 [TBL] [Abstract][Full Text] [Related]
91. CSF substance P immunoreactivity in affective disorders. Berrettini WH; Rubinow DR; Nurnberger JI; Simmons-Alling S; Post RM; Gershon ES Biol Psychiatry; 1985 Sep; 20(9):965-70. PubMed ID: 2411304 [TBL] [Abstract][Full Text] [Related]